Observation on the Effectiveness of Yinzhihuang Granules in the Treatment of Neonatal Jaundice

Objective: To analyze the therapeutic efficacy of Yinzhihuang granules in treating neonatal jaundice. Methods: A total of 62 neonates with jaundice, admitted from September 2021 to September 2023, were randomly divided into two groups. The observation group received Yinzhihuang granules, while the control group received conventional blue light therapy. The overall efficacy rate and other indicators were compared. Results: The observation group showed a higher overall efficacy rate and superior clinical indicators compared to the control group (P < 0.05). Before treatment, there was no significant difference between the two groups in bilirubin, liver function, or immune function indicators (P > 0.05). After one week of treatment, the observation group had lower bilirubin and liver function indicators and higher immune function indicators than the control group (P < 0.05). Conclusion: Yinzhihuang granules can improve the efficacy of neonatal jaundice treatment, accelerate recovery, reduce bilirubin levels, protect liver function, and enhance immune function in neonates.